A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Explore Mesoblast Limited's advancements in cell therapies, from FDA alignments to key trials. Click for MESO opportunities ...

EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food ...

This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...

Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.

Investing.com -- Mustang Bio Inc (NASDAQ: MBIO) stock surged over 78% after the U.S. Food and Drug Administration granted orphan drug designation to its MB-101 treatment for recurrent diffuse and ...

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

Investing.com -- Lexeo Therapeutics Inc (NASDAQ: LXEO) stock rose 2.3% after the company announced that the U.S. Food and Drug Administration granted breakthrough therapy designation for its ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...